EGRIFTA™ (Tesamorelin for Injection) Approved in Mexico

Jul 14, 2015
PDF Version
Supporting Materials:

Theratechnologies Inc. (Theratechnologies) (TSX: TH) is pleased to announce that COFEPRIS, Mexico’s health agency, has approved the 2mg/vial presentation of tesamorelin for the treatment of lipodystrophy.